Plasma lipids and lipoproteins in long-term beta-adrenergic blockade.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D013997:Time Factors; D014280:Triglycerides / Q000097:blood*
D000319:Adrenergic beta-Antagonists; D008074:Lipoproteins; D014280:Triglycerides; D000526:Alprenolol; D002784:Cholesterol